Stage III Ovarian Epithelial Cancer Completed Phase 1 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028510 (Stage III Ovarian Epithelial Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00085358Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)Treatment